Features of the Legal Regulation of Biobank Bankruptcy in the Russian Federation

The rapid development of biomedical technologies and the growing number of biobanks in the Russian Federation underscores the importance of their legal regulation, particularly in relation to potential insolvency (bankruptcy). This study aims to identify the specific features of legal regulation of biobank bankruptcy, taking into account the unique nature of their assets and their social significance. The research was conducted using an integrated approach, including an analysis of bankruptcy legislation and civil law governing the circulation of biological materials, judicial practice, and doctrinal sources. The research methodology involved the principles of analysis and synthesis, comparative and formal legal analysis, as well as the method of systems analysis. The conducted research has revealed gaps and ambiguities in the current legal regulation of biobank bankruptcy, particularly concerning the legal status of biological materials, procedures for their valuation and inclusion in the bankruptcy estate, and the protection of donors’ and patients’ rights. Risks associated with the potential misuse or improper disposal of biological materials during bankruptcy proceedings are identified. In conclusion, recommendations for improving bankruptcy legislation to reflect the specific characteristics of biobank activities are provided. These recommendations aim to ensure the safety of biological materials, safeguard the rights of donors and patients, and enhance the transparency and predictability of biobank bankruptcy procedures. The study emphasizes the need to develop special rules for regulating the bankruptcy of biobanks, taking into account their operational particularities and the unique nature of their assets